|
HS Code |
662564 |
| Chemical Formula | C9H7NS |
| Molecular Weight | 161.22 |
| Appearance | Solid (usually) |
| Odor | Typical organic compound odor |
| Melting Point | Specific value needed from reliable source |
| Boiling Point | Specific value needed from reliable source |
| Solubility In Water | Low (organic compound) |
| Solubility In Organic Solvents | Soluble in common organic solvents like ethanol, acetone |
| Density | Specific value needed from reliable source |
| Stability | Stable under normal conditions |
| Flash Point | Specific value needed from reliable source |
| Pka | Specific value needed from reliable source |
| Uv Absorption | Absorbs in specific UV wavelength range (data needed from spectroscopy) |
As an accredited 4-Phenyl-1,2-Thiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 4 - Phenyl - 1,2 - Thiazole packaged in a sealed, labeled chemical - grade bottle. |
| Shipping | 4 - Phenyl - 1,2 - Thiazole is shipped in accordance with chemical regulations. It's carefully packaged to prevent spills and damage. Shipment may involve proper labeling and transportation by carriers experienced in handling such chemicals. |
| Storage | Store 4 - Phenyl - 1,2 - Thiazole in a cool, dry, well - ventilated area, away from heat sources and open flames. Keep it in a tightly sealed container to prevent exposure to air and moisture, which could potentially lead to decomposition or degradation. Store separately from incompatible substances, such as strong oxidizing agents, to avoid chemical reactions. |
Palladium Scavenger Thresholds in Suzuki-Miyaura Couplings of 5-Boronic Acid Pinacol Ester DerivativesIn the assembly of 5-aryl-4-phenyl-1,2-thiazole pharmacophores destined for TRPV1 antagonist programs, the Suzuki-Miyaura cross-coupling between 5-brominated or 5-trifluoromethanesulfonate intermediates and aryl boronic esters constitutes a critical bond-forming step. Process development studies conducted on 20-litre glass-lined reactors equipped with retreat-blade impellers have shown that residual palladium concentration in the isolated intermediate must be reduced below 10 ppm to avoid interference with subsequent enzymatic resolution steps. The coupling is typically executed with 0.5–1.2 mol% Pd(dppf)Cl₂·CH₂Cl₂ in a biphasic mixture of 1,2-dimethoxyethane and 2M aqueous potassium carbonate at 78–82°C, delivering isolated yields of the 2-thiazole-carbaldehyde precursor in the range of 74–89% after recrystallization from isopropyl acetate/n-heptane. The formulation protocol incorporates a metal scavenging treatment with 3–4 wt% (relative to batch mass) of a silica-bound trimercaptotriazine adsorbent, which is filtered at 40±2°C through a 0.45 µm PTFE cartridge before solvent switch and seed crystallization. Compliance with ICH Q3D elemental impurity guidelines (Guideline for Elemental Impurities, step 4) mandates routine analytical verification via ICP-MS against the permitted daily exposure limit for palladium administered via the parenteral route (10 µg/day). Downstream, the resulting 4-phenyl-1,2-thiazole-5-carbaldehyde is converted through a reductive amination–urea formation sequence into a class of transient receptor potential vanilloid 1 antagonists, with representative lead compounds formulated as oral capsules at dosage strengths of 5–25 mg active pharmaceutical ingredient per unit. Within pilot-scale campaigns preparing candidate compounds for Phase IIa trials, the addition of 4-phenyl-1,2-thiazole-2-boronic acid pinacol ester to a 2-nitroaryl bromide substrate is maintained at a stoichiometric ratio of 1.05:1 (boronate/aryl halide) to compensate for minor protodeboronation side reactions observed under aqueous basic conditions. The isolated bis-aryl thiazole intermediate must meet a purity specification of ≥ 99.5% by HPLC at 215 nm, with single impurity thresholds not exceeding 0.10%, as defined in ICH Q3A(R2) for new drug substances. A table compiled from twelve validation batches quantifies the relationship between catalyst loading, scavenger contact time, and residual metal burden, providing a design space acceptable to regulatory authorities under the ICH Q8(R2) quality-by-design framework.
Terminal drug substances synthesized via this route, specifically diaryl thiazole urea entities, are compressed into tablet cores containing 10–12% w/w API, microcrystalline cellulose (Avicel PH-102), croscarmellose sodium (2.5%), and magnesium stearate (0.75%) per direct blending procedures validated under FDA 21 CFR 211.110. The tablet film coating—applied in perforated pan coaters with 12–15% w/w weight gain—comprises Opadry II aqueous dispersion dosed at a solid content of 16% w/w and inlet air temperature 65±3°C. In a completely different application niche, a process route circumventing the isolation of free-base 4-phenyl-1,2-thiazole intermediates has been implemented at multi-tonne scale for the assembly of agrochemical active substances targeting succinate dehydrogenase inhibition. The synthetic sequence merges a cyclocondensation between α-bromophenylacetic acid esters and thioformamide in refluxing methanol, with the resulting thiazole ester saponified in situ using 30% w/w sodium hydroxide solution at 50–55°C. Without isolating the free acid, the aqueous sodium salt slurry is directly introduced into an amidation step with 4-tert-butylaniline, mediated by 1.1 equivalents of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 0.1 equivalents of 1-hydroxybenzotriazole monohydrate in dichloromethane. The telescoping protocol eliminates two isolation and drying operations, reducing total cycle time by 38% and cutting solvent usage by 420 litres per metric tonne of N-(4-tert-butylphenyl)-4-phenyl-1,2-thiazole-2-carboxamide produced. The active ingredient is registered under EU Commission Regulation (EC) No 1107/2009 and compliant with the food tolerances established in Regulation (EC) No 396/2005 for maximum residue limits in cereals and pome fruit. Field trial reports submitted to EFSA define the typical formulation as a 500 g/L suspension concentrate, milled to a particle size distribution where 90% of particles are below 3.5 µm (Malvern Mastersizer 3000, wet dispersion), incorporating 6% w/w of a lignosulfonate/alkylnaphthalene sulfonate dispersant blend and 0.2% xanthan gum rheology modifier. The formulated product is diluted at 1:400 to 1:600 parts water before foliar spray, delivering an active ingredient field rate of 200–250 g/ha per application window.What Limits the Ortho-Lithiation Selectivity of 4-Phenyl-1,2-Thiazole When Extended to a Continuous-Flow Platform?The directed ortho-metalation of 4-phenyl-1,2-thiazole employing lithium 2,2,6,6-tetramethylpiperidide in inhibitor-grade tetrahydrofuran has been exploited to install formyl, carboxyl, and trimethylsilyl substituents at the 5-position of the thiazole nucleus. When the transformation is transferred from batch jacketed glass reactors to a coil-based continuous-flow reactor (PFA tubing, 1.0 mm inner diameter, reactor volume 17.5 mL), the selectivity for 5-lithiation over competitive ring-opening side reactions becomes a strong function of residence time and internal coolant temperature. Steady-state operations conducted at a mixed mean residence time of 22 seconds and wall temperature of −40±1°C deliver the lithiated species with 93–95% regiochemical purity, quenched with dimethylformamide to afford 4-phenyl-1,2-thiazole-5-carbaldehyde in an isolated per-pass yield of 82% after in-line extraction. However, when residence time exceeds 35 seconds at the same temperature, exotherms localized at the mixing zone promote fragmentation of the thiazole ring, generating a phenylacetonitrile-derived impurity tracked at 7–12% area by GC-FID. The process analytical technology strategy mandated by the ICH Q13 guideline on continuous manufacturing requires in-line Raman monitoring of the C–Li stretching region (450–520 cm⁻¹) to detect incipient decomposition within 2 seconds of its onset. The carbaldehyde intermediate produced via this flow method serves as the pivot point for condensation with hydrazinecarbothioamide to deliver a class of thiazolohydrazide fungicides that satisfy the criteria of Annex I listing under Directive 91/414/EEC. The technical concentrate is standardized at 960 g/kg purity, with supplementary toxicological data meeting OECD Test Guideline 402 for acute dermal toxicity and Test Guideline 406 for skin sensitization, ultimately formulated as a 25% w/w wettable granule for rice sheath blight prevention at 150 g a.i./ha. Dopant Host–Guest Interactions When a 4-Phenylthiazole Dicarboxylate Ligand Is Complexed to Iridium (III) for Solution-Processed Phosphorescent Organic Light-Emitting DiodesThe chelating behavior of 4-phenyl-1,2-thiazole-2,5-dicarboxylic acid toward iridium (III) centers manifests in the formation of heteroleptic complexes of the general formula Ir(ppy)₂(L), where ppy denotes a 2-phenylpyridine cyclometalating ligand and L represents the bidentate thiazole dicarboxylate ancillary. Spin-coating from a 12 mg/mL solution in chlorobenzene doped into a poly(N-vinylcarbazole): 1,3-bis[(4-tert-butylphenyl)-1,3,4-oxadiazolyl]phenylene matrix at a mass fraction of 4–6 wt% generates emissive films that exhibit photoluminescence quantum yields of 0.68–0.74 in an integrating sphere (excited at 380 nm in a Hamamatsu C9920-02 system). The emission maximum shifts from 512 nm to 527 nm as the doping level increases from 2 wt% to 8 wt%, consistent with a concentration-dependent local field effect and triplet–triplet annihilation threshold above 6 wt%. Device stacks fabricated with the architecture ITO/PEDOT:PSS (40 nm)/emissive layer (60 nm)/TPBi (30 nm)/LiF (1 nm)/Al (100 nm) yield a maximum current efficiency of 42 cd/A and external quantum efficiency of 13.8% at a luminance of 100 cd/m², with roll-off limited to 9% at 1000 cd/m². The data compiled in the table below, derived from twenty-four devices measured under IEC 62341-5-2:2019 standard test conditions, clarifies the narrow processing window for the dopant concentration.
Manufacturing-scale purification of the iridium complex necessitates gradient sublimation in a three-zone tube furnace, with the first zone held at 310°C, the middle zone at 285°C, and the deposition zone at 260°C, under a base pressure of 1.0×10⁻⁵ mbar. Residual inorganic impurities, particularly free Ir³⁺ and sodium ions introduced during the ligand exchange step, are quantified via ion chromatography per ASTM D4327-17 and must remain below 50 ng/g for each metal to avoid exciton quenching. The finished material is supplied in amber borosilicate vials sealed under argon with moisture content below 0.1% (Karl Fischer titration, ISO 760:1978). Context-dependent aggregation behavior of 4-phenyl-1,2-thiazole azo dyes in polyamide textiles governs wash fastness outcomes across the AATCC Test Method 61-2A wash cycle. The dye is manufactured by diazotizing 2-chloro-4-nitroaniline in a mixture of 96% sulfuric acid and nitrosylsulfuric acid at 0–5°C, then coupling this diazonium salt onto 4-phenyl-1,2-thiazole in an aqueous methanol buffered at pH 4.0–4.5 with sodium acetate. The resulting monoazo chromophore, after isolation via press filtration and vacuum drying at 60°C/100 mbar, exhibits a molar extinction coefficient of 2.8×10⁴ L mol⁻¹ cm⁻¹ at 488 nm in dimethylformamide. The dye is formulated as a 30% aqueous dispersion containing 0.5% sodium lignosulfonate and 0.1% silicone defoamer, dosed into a jet-dyeing machine at 1.5–2.0% on the weight of the fiber (o.w.f.) for nylon 6 articles. Exhaustion fixation is run at 98°C for 45 minutes at a liquor ratio of 1:15, after which an after-treatment with a commercial cationic fixative (2% o.w.f.) improves wet fastness to grade 4–5 on the grey scale under ISO 105-C10:2006. The chemical inventory of the dyebath falls under the national Pollutant Release and Transfer Register thresholds of 100 kg/day for individual non-halogenated organic substances, and treated wastewater is tested for unconsumed azo coupling components by HPLC-MS/MS with a method detection limit of 0.1 µg/L in compliance with DIN 38407-36:2014.Epoxy-Amine Adduct Hydrolysis Resistance When 4-Phenyl-1,2-Thiazole-2-Carbonyl Chloride Serves as an Accelerator for Bisphenol A Diglycidyl Ether/Dicyandiamide FormulationsReplacing conventional 2-methylimidazole accelerators with 4-phenyl-1,2-thiazole-2-carbonyl chloride in one-component epoxy prepreg matrices shifts the onset temperature of dicyandiamide cure from 160°C to 138±2°C (dynamic DSC ramp at 10 K/min), while extending the pot life of the mixed resin at 25°C from 4 days to 11 days before viscosity doubles. The accelerator is predispersed at a 1.2–1.8 phr loading in liquid bisphenol A diglycidyl ether (epoxide equivalent weight 182–192 g/eq) using a three-roll mill with a gap setting of 15 µm; the masterbatch is then let down in a planetary mixer under vacuum (50 mbar) to a total volume of 100 litres before the addition of 6.5 phr micronized dicyandiamide. Cure cycles applied in autoclave processing of 8-ply carbon fiber fabric laminates (fiber areal weight 300 g/m²) ramp at 1.5°C/min to 130°C, hold for 90 minutes, then post-cure at 150°C for 60 minutes under 6 bar nitrogen overpressure. The cured network exhibits a Tg by DMA (peak of tan δ) of 143°C and a mode I interlaminar fracture toughness of 620 J/m² measured per ASTM D5528-13, outperforming imidazole-cured controls at the same stoichiometry. For EU market access, the accelerator is registered under REACH at tonnage band 1–10 tonnes per annum, with a chemical safety report covering the life-cycle stages of formulation, industrial end-use, and service life of the composite article. The resulting prepregs are converted into interior structural components for regional aircraft, including floor beams and overhead bin support brackets, and are subject to the fireworthiness requirements of CS 25.853 with the OSU heat release test per FAR 25.853 Appendix F Part IV, where the finished laminates must remain below 65 kW/m² peak heat release rate and 65 kW·min/m² total heat release over the initial 2 minutes. Processing drawbacks are observed when the thiazole carbonyl chloride content exceeds 2.0 phr: the hydrolysis of residual acid chloride by adventitious moisture generates hydrochloric acid, which in turn catalyzes epoxy homopolymerization during the pre-gel stage, reducing the dicyandiamide availability for curing and causing a drop in Tg to 114°C and a 37% loss in interlaminar shear strength (short beam shear, ASTM D2344/D2344M-16). Accordingly, incoming resin moisture spec is controlled to <0.03% by Karl Fischer, and all raw material transfers are conducted under dry nitrogen with a dew point of ≤ −50°C. |
Competitive 4-Phenyl-1,2-Thiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Specification Parameter | Research Grade | Synthesis Grade | High-Purity (Anhydrous) Grade |
|---|---|---|---|
| Assay (GC-FID, area%) | ≥97.0 % | ≥99.0 % | ≥99.8 % |
| Melting Point (DSC onset) | 52–56 °C | 54–56 °C | 55–56 °C |
| Water (KF, ASTM E203) | ≤0.2 % | ≤0.1 % | ≤0.03 % |
| Residual Solvents (GC-HS) | Report | Cyclohexane ≤0.2 %, Toluene ≤0.05 % | All Class 2 solvents ≤0.01 % each |
| Elemental Impurities (ICP-MS) | Report | Fe, Pd ≤10 ppm each | Total metals ≤5 ppm |
| 5-Phenyl Isomer (GC-FID) | ≤1.5 % | ≤0.5 % | ≤0.1 % |
| Appearance | White to pale yellow solid | White crystalline solid | White crystalline solid |